Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies
Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320)
10/2014
10/09/2014US20140301993 Fully human, anti-mesothelin specific chimeric immune receptor for redirected mesothelin-expressing cell targeting
10/09/2014US20140301977 Overload and elute chromatography
10/09/2014US20140301946 Antibody drug conjugates
10/09/2014US20140301945 Human anti-sod1 antibodies
10/08/2014EP2787346A1 Biomarker for lymphocytic infundibuloneurohypophysitis, and use applications thereof
10/08/2014EP2787081A1 Drug containing carrier into cell for forming immune complex
10/08/2014EP2787079A1 IgA-BINDING PEPTIDE AND PURIFICATION OF IgA THEREBY
10/08/2014EP2787078A1 Antigen-binding molecule having regulated conjugation between heavy-chain and light-chain
10/08/2014EP2787008A1 Anti-idiotype antibody against anti-C-met antibody
10/08/2014EP2787007A2 Subcutaneously administered ANTI-IL-6 receptor antibody
10/08/2014EP2787006A1 Anti-CD8 antibody which binding is Ca2+ dependent
10/08/2014EP2787005A1 Targeted cancer immune therapy
10/08/2014EP2786765A2 Composition for combination therapy comprising an anti-C-met antibody and a FGFR inhibitor
10/08/2014EP2786764A2 Combination therapy using anti-c-met antibody and sorafenib
10/08/2014EP2786762A2 Covalent diabodies and uses thereof
10/08/2014EP2786657A2 A method of producing an antibody comprising a human variable region and a rodent constant region.
10/08/2014EP2785833A1 Method to improve the immune function of t cells
10/08/2014EP2785743A1 Anti-ceacam1 recombinant antibodies for cancer therapy
10/08/2014EP2785742A1 Anti-kdr antibodies and methods of use
10/08/2014EP2785741A1 Antibodies against hgf - receptor and uses
10/08/2014EP2785740A1 Anti-glucagon antibodies and uses thereof
10/08/2014EP2785739A1 Improving trabeculectomy outcome
10/08/2014EP2785738A1 Anti-npy and pyy antibodies and uses thereof
10/08/2014EP2785737A2 Influenza a virus specific antibodies
10/08/2014EP2785736A2 Assays, antibodies, immunogens and compositions related to 5-fu
10/08/2014EP2785731A1 Vectors and host cells comprising a modified sv40 promoter for protein expression
10/08/2014EP2785375A1 Anti-pd-l1 antibodies and uses thereof
10/08/2014EP2785368A1 Immunogenic composition comprising panton-valentine leukocidin (pvl) derived polypeptides
10/07/2014US8853382 Expression of antibody or a fragment thereof in lactobacillus
10/07/2014US8853370 Plant-produced glycoprotein comprising human-type sugar chain
10/07/2014US8853369 Anti-Axl antibodies and methods of use
10/07/2014US8853368 Human antibodies against human glycoprotein VI and their use
10/07/2014US8853366 Binding domain-immunoglobulin fusion proteins
10/07/2014US8853365 Dual variable domain immunnoglobulins and uses thereof
10/07/2014US8853364 Prostate stem cell antigen (PSCA) variants and subsequences thereof
10/07/2014US8853363 Substance binding human IgG Fc receptor IIb (FcγRIIb)
10/07/2014US8853362 Immunoglobulin frameworks which demonstrate enhanced stability in the intracellular environment and methods of identifying same
10/07/2014US8853183 Prognosis and treatment of breast cancer
10/07/2014US8853154 Fibronectin based scaffold domain proteins that bind to myostatin
10/07/2014US8853146 Hapten compounds and compositions and uses thereof
10/07/2014US8852953 Immunodetection and quantification of pyrazolopyrimidine sedatives
10/07/2014US8852889 Cell culture process
10/07/2014US8852887 Antibodies against human tweak and uses thereof
10/07/2014US8852883 Rapid FRET-based diagnosis of bacterial pathogens
10/07/2014US8852879 Materials and methods for the detection of nitrated fibrinogen
10/07/2014US8852872 Methods for detecting oncofetal fibronectin
10/07/2014US8852871 Humanized anti-IL-10 antibodies for the treatment of systemic lupus erythematosus (SLE)
10/07/2014US8852606 Capsular polysaccharide solubilisation and combination vaccines
10/07/2014US8852603 Inhibition of secretion from non-neuronal cells
10/07/2014US8852599 Immunoconjugates, compositions for making them, and methods of making and use
10/07/2014US8852597 Anti-CD154 antibodies having impaired FcR binding and/or complement binding properties
10/07/2014US8852595 Human binding molecules capable of binding to and neutralizing influenza B viruses and uses thereof
10/07/2014US8852593 Antagonist antibodies and their fab fragments against GPVI and uses thereof
10/07/2014US8852592 Systems and methods for anti-PAX8 antibodies
10/07/2014US8852589 Antibodies against IL-17BR
10/07/2014US8852588 Treating allergic airway disorders using anti-IL-20 receptor antibodies
10/07/2014US8852586 Fc variants with altered binding to FcRn
10/07/2014US8852585 Method of treatment and prophylaxis of diseases related to amyloid deposition using IgM
10/07/2014US8852551 Methods to impair hematologic cancer progenitor cells and compounds related thereto
10/07/2014US8851893 Interactive dental restorative network
10/02/2014WO2014160958A1 Compositions and methods for increasing the serum half-life of a therapeutic agent targeting complement c5
10/02/2014WO2014160627A1 Anti-cd276 polypeptides, proteins, and chimeric antigen receptors
10/02/2014WO2014160441A1 Neuroactive steroids, compositions, and uses thereof
10/02/2014WO2014160336A1 METHODS OF ADMINISTERING IgG1 ANTIBODIES AND METHODS OF SUPPRESSING ANGIOGENESIS
10/02/2014WO2014160202A1 Mice expressing a limited immunoglobulin light chain repertoire
10/02/2014WO2014160179A1 Common light chain mouse
10/02/2014WO2014160133A2 Anti-(+) --methamphetamine monoclonal antibodies
10/02/2014WO2014160075A1 Antibody-nanoparticle conjugates for the treatment of drug abuse
10/02/2014WO2014159960A1 Antibodies against influenza virus hemagglutinin and uses thereof
10/02/2014WO2014159915A1 Her3 specific monoclonal antibodies for diagnostic and therapeutic use
10/02/2014WO2014159911A1 Compositions comprising anti-cd38 antibodies and carfilzomib
10/02/2014WO2014159835A1 Anti-b7-h4 antibodies and immunoconjugates
10/02/2014WO2014159764A1 Chrdl-1 antigen binding proteins and methods of treatment
10/02/2014WO2014159725A1 Proteins specific for baff and b7rp1 and uses thereof
10/02/2014WO2014159609A1 Peanut formulations and uses thereof
10/02/2014WO2014159607A1 Manufacture of peanut formulations for oral desensitization
10/02/2014WO2014159595A2 Human antibodies to nav1.7
10/02/2014WO2014159580A1 Met-binding agents and uses thereof
10/02/2014WO2014159579A1 MUTATED ANTI-TNFα ANTIBODIES AND METHODS OF THEIR USE
10/02/2014WO2014159562A1 Combination of dr5 agonist and anti-pd-1 antagonist and methods of use
10/02/2014WO2014159554A1 Low acidic species compositions and methods for producing the same using displacement chromatography
10/02/2014WO2014159531A1 Monoclonal antibodies targeting epcam for detection of prostate cancer lymph node metastases
10/02/2014WO2014159441A1 Removal of leaked affinity purification ligand
10/02/2014WO2014159430A1 Anti-rankl antibodies and methods of use
10/02/2014WO2014159259A1 Methods for increasing mannose content of recombinant proteins
10/02/2014WO2014159244A2 O-GlcNAc TAU ANTIBODY AND USE THEREOF
10/02/2014WO2014159242A1 Notch 3 mutants and uses thereof
10/02/2014WO2014159074A1 Fam150a, fam150b, and fam150 antagonists and uses thereof
10/02/2014WO2014159010A1 Human antibodies to grem 1
10/02/2014WO2014158542A1 Biomarkers for detecting the presence of bacteria
10/02/2014WO2014158231A1 Low acidic species compositions and methods for producing and using the same
10/02/2014WO2014157952A1 Novel syndecan-2 fragment and use thereof
10/02/2014WO2014157229A1 Tace peptide epitope, antihuman tace protein antibody and hybridoma producing antibody
10/02/2014WO2014154930A1 Anti-factor b antibody, pharmaceutical composition that can be used for the treatment of diseases of the complement system, and uses thereof
10/02/2014WO2013122544A9 IL-1β NEUTRALIZING HUMAN MONOCLONAL ANTIBODIES
10/02/2014US20140298538 Axmi205 variant proteins and methods of use
10/02/2014US20140298498 Inhibition of oncogenic kras-induced gm-csf production and function
10/02/2014US20140296493 METHOD OF TREATING DEPRESSION USING A TNFa ANTIBODY
10/02/2014US20140296492 Hla-restricted, peptide-specific antigen binding proteins
10/02/2014US20140296491 Generating metal ion binding proteins
1 ... 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 ... 1494